围生期合并重症感染患者个体化药学监护策略

Individualized pharmaceutical care strategy for patients with severe infection in perinatal period

目的:探讨临床药师参与围生期合并重症感染患者个体化药物治疗中的作用。方法:临床药师发挥自身药学专业特长,根据围生期妇女特殊的生理结构,分析药代动力学和药效学特点,同时结合药物不良反应与相互作用,协助南京医科大学附属苏州医院重症医学科医护人员参与围生期合并重症感染患者的个体化治疗。结果:通过药学监护,临床药师为围生期合并重症感染患者的成功救治提供了合理安全的用药方案,取得了良好的治疗效果。结论:临床药师与重症医学科医护人员组成多学科诊疗团队,有利于提高临床治疗水平,保障围生期危重症患者应用药物的安全性和有效性。

Objective： To investigate the role of clinical pharmacist in the individualized treatment of patients with severe infection in perinatal period. Methods： During the individualized treatment for patients with severe infection in perinatal period, clinical pharmacists bring their own pharmacy expertise into full play and help physicians in adjusting dose regimen and rational choice of medication based on the special physiological structures of women in perinatal period, pharmacokinetic and pharmacodynamics characteristics and experience in drug use. Results： With individualized regimen, patients with severe infection in perinatal period were successfully rescued. Conclusion：The participation of clinical pharmacist in clinical treatment is conducive to improving the clinical treatment and promoting rational use of medication. It can improve the safety and effectiveness of treatment in patients with severe diseases in perinatal period and reflect the role of clinical pharmacists in rational use of drugs.